Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Paul Senior who wrote (42929)	6/6/2011 10:22:23 AM
From: E_K_S	of 78748

Re: Covidien plc (COV) After a quick review, I will continue to hold my 50% position in COV. Their forward PE is still quite attractive at 12.78 according to Yahoo. 22 analysts follow the stock and the consensus earnings for 2012 is $4.23/share. Other medical device makers demand at least a 15 PE which would price the stock at $63.45 fair value. Based on the current price of $53.70/share there is a potential 19% upside gain. This position is also a somewhat defensive hold since one pretty much has to have their medical device(s) when prescribed. My initial buy was on 11/01/2010 at $39.34/share. Sold 50% on 2/1/2011 at $49.50/share. ----------------------------------------------------------------------- The two sectors that are looking attractive to me on further sell offs are : (1) The integrated AG companies (BG, AGU) and (2) REIT data centers (DLR, COR). Some special situation small Cap E&P companies are also being sold on these waves of down days. I will continue to nibble at those too. EKS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next